Hsa-miR-625 Upregulation Promotes Apoptosis in Acute Myeloid Leukemia Cell Line by Targeting Integrin-linked Kinase Pathway

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• MicroRNAs play a crucial role in cancer development, including acute myeloid leukemia (AML).
• Overexpression of miR-625 may inhibit AML tumorgenesis via the Integrin-linked kinase (ILK) signaling pathway.
• This study investigates the impact of hsa-miR-625 upregulation on KG1 cell apoptosis and proliferation through the ILK pathway.

Purpose of the Study:

• To evaluate the effect of hsa-miR-625 upregulation on apoptosis and proliferation in the KG1 cell line.
• To investigate the role of the Integrin-linked kinase (ILK) signaling pathway in mediating these effects.

Main Methods:

• Transfection of KG-1 cells with pLenti-III-premir625-GFP using a viral method.
• Quantitative PCR and Western blotting to analyze gene and protein expression levels.
• Flow cytometry for apoptosis assessment, and PI/CCK-8 assays for proliferation analysis.

Main Results:

• Transfection with pLenti-III-pre mir625-GFP significantly increased KG-1 cell apoptosis.
• Downregulation of ILK and NF-κB gene expression, with upregulation of AKT, c-fos, Caspase3, cyclin D1, KLF-4, OCT-4, and Nanog.
• Protein analysis revealed downregulation of NF-κB and upregulation of Caspase 3 and p-β-catenin.

Conclusions:

• Hsa-miR-625 upregulation demonstrates potential as a therapeutic strategy for AML.
• Further research is warranted to fully elucidate the therapeutic implications of miR-625 in AML treatment.